Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gunnlaugur Petur Nielsen, M.D.

Co-Author

This page shows the publications co-authored by Gunnlaugur Nielsen and Thomas Delaney.
Connection Strength

2.079
  1. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):85-93.
    View in: PubMed
    Score: 0.173
  2. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine. 2015 Dec; 23(6):788-97.
    View in: PubMed
    Score: 0.158
  3. Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy. Cancer. 2014 Dec 01; 120(23):3676-82.
    View in: PubMed
    Score: 0.146
  4. Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol. 2014 Aug; 110(2):115-22.
    View in: PubMed
    Score: 0.143
  5. The use of radiation therapy in the management of selected patients with atypical lipomas. Sarcoma. 2013; 2013:485483.
    View in: PubMed
    Score: 0.131
  6. Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):1081-90.
    View in: PubMed
    Score: 0.112
  7. Management of acral myxoinflammatory fibroblastic sarcoma. Cancer. 2010 Dec 15; 116(24):5733-9.
    View in: PubMed
    Score: 0.111
  8. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol. 2010 Jun; 17(6):1515-29.
    View in: PubMed
    Score: 0.107
  9. An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):843-50.
    View in: PubMed
    Score: 0.106
  10. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):732-9.
    View in: PubMed
    Score: 0.099
  11. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1460-9.
    View in: PubMed
    Score: 0.088
  12. Results of radiotherapy performed after unplanned surgery (without reexcision) for soft tissue sarcomas. J Clin Oncol. 2005 Jun; 23(16_suppl):9021.
    View in: PubMed
    Score: 0.077
  13. Assessing the Safety and Utility of Wound VAC Temporization of the Sarcoma or Benign Aggressive Tumor Bed Until Final Margins Are Achieved. Ann Surg Oncol. 2022 Apr; 29(4):2290-2298.
    View in: PubMed
    Score: 0.061
  14. Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution. Sarcoma. 2019; 2019:9069272.
    View in: PubMed
    Score: 0.053
  15. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis. Clin Orthop Relat Res. 2019 Sep; 477(9):2114-2126.
    View in: PubMed
    Score: 0.052
  16. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST. Radiother Oncol. 2019 08; 137:61-70.
    View in: PubMed
    Score: 0.051
  17. Clinicopathologic characteristics of poorly differentiated chordoma. Mod Pathol. 2018 08; 31(8):1237-1245.
    View in: PubMed
    Score: 0.047
  18. Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for Screening. Spine (Phila Pa 1976). 2017 Jan 01; 42(1):E37-E40.
    View in: PubMed
    Score: 0.043
  19. Differences in sex distribution, anatomic location and MR imaging appearance of pediatric compared to adult chordomas. BMC Med Imaging. 2016 09 08; 16(1):53.
    View in: PubMed
    Score: 0.042
  20. The Width of the Surgical Margin Does Not Influence Outcomes in Extremity and Truncal Soft Tissue Sarcoma Treated With Radiotherapy. Oncologist. 2016 10; 21(10):1269-1276.
    View in: PubMed
    Score: 0.042
  21. Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery. J Surg Oncol. 2014 Dec; 110(7):817-22.
    View in: PubMed
    Score: 0.037
  22. Epithelioid hemangioma of the spine: a case series of six patients and review of the literature. Spine J. 2013 Dec; 13(12):e7-13.
    View in: PubMed
    Score: 0.034
  23. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. Eur J Cancer. 2013 Mar; 49(4):875-83.
    View in: PubMed
    Score: 0.032
  24. Prognostic factors and outcomes of patients with myxofibrosarcoma. Ann Surg Oncol. 2013 Jan; 20(1):80-6.
    View in: PubMed
    Score: 0.032
  25. Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center. Spine (Phila Pa 1976). 2012 Jan 15; 37(2):119-26.
    View in: PubMed
    Score: 0.031
  26. Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Ann Surg Oncol. 2009 May; 16(5):1356-63.
    View in: PubMed
    Score: 0.025
  27. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007 Jun; 14(6):1953-67.
    View in: PubMed
    Score: 0.022
  28. Platelet-derived growth factor receptor-beta in Gorham's disease. Nat Clin Pract Oncol. 2006 Dec; 3(12):693-7.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.